USD 2.16
(-8.86%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -43.1 Million USD | 14.12% |
2022 | -50.18 Million USD | -62.54% |
2021 | -30.87 Million USD | -2.9% |
2020 | -30 Million USD | 30.38% |
2019 | -43.1 Million USD | -32.82% |
2018 | -32.45 Million USD | -164.08% |
2017 | -12.28 Million USD | 6.73% |
2016 | -13.17 Million USD | 8.98% |
2015 | -14.47 Million USD | 5.13% |
2014 | -15.25 Million USD | 5.68% |
2013 | -16.17 Million USD | -36.26% |
2012 | -11.87 Million USD | -31.84% |
2011 | -9 Million USD | 17.97% |
2010 | -10.97 Million USD | 46.43% |
2009 | -20.48 Million USD | -44.41% |
2008 | -14.18 Million USD | 2.44% |
2007 | -14.54 Million USD | -49.56% |
2006 | -9.72 Million USD | -91.74% |
2005 | -5.07 Million USD | 27.97% |
2004 | -7.04 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -8.51 Million USD | 20.61% |
2024 Q2 | -11.52 Million USD | -35.45% |
2023 Q1 | -14.7 Million USD | -18.19% |
2023 Q4 | -10.72 Million USD | -6.72% |
2023 FY | -43.1 Million USD | 14.12% |
2023 Q2 | -10.62 Million USD | 27.72% |
2023 Q3 | -10.04 Million USD | 5.47% |
2022 Q2 | -9.83 Million USD | -13.19% |
2022 FY | -50.18 Million USD | -62.54% |
2022 Q3 | -13.5 Million USD | -37.3% |
2022 Q4 | -12.43 Million USD | 7.88% |
2022 Q1 | -8.68 Million USD | -7.5% |
2021 Q3 | -7.62 Million USD | -7.1% |
2021 Q4 | -8.08 Million USD | -6.05% |
2021 FY | -30.87 Million USD | -2.9% |
2021 Q1 | -6.18 Million USD | 17.3% |
2021 Q2 | -7.11 Million USD | -15.09% |
2020 Q2 | -6.85 Million USD | 0.0% |
2020 FY | -30 Million USD | 30.38% |
2020 Q1 | -6.85 Million USD | 52.67% |
2020 Q4 | -7.47 Million USD | 0.0% |
2020 Q3 | -7.47 Million USD | -9.07% |
2019 Q4 | -14.48 Million USD | 0.0% |
2019 FY | -43.1 Million USD | -32.82% |
2019 Q1 | -7.06 Million USD | 18.45% |
2019 Q2 | -7.06 Million USD | 0.0% |
2019 Q3 | -14.48 Million USD | -104.85% |
2018 Q4 | -8.66 Million USD | 0.0% |
2018 FY | -32.45 Million USD | -164.08% |
2018 Q1 | -7.55 Million USD | -17.83% |
2018 Q2 | -7.55 Million USD | 0.0% |
2018 Q3 | -8.66 Million USD | -14.72% |
2017 Q3 | -6.41 Million USD | -2484.01% |
2017 Q2 | 269 Thousand USD | 0.0% |
2017 Q4 | -6.41 Million USD | 0.0% |
2017 Q1 | 269 Thousand USD | 109.68% |
2017 FY | -12.28 Million USD | 6.73% |
2016 Q4 | -2.77 Million USD | 0.0% |
2016 Q1 | -3.8 Million USD | 15.25% |
2016 Q3 | -2.77 Million USD | 27.07% |
2016 Q2 | -3.8 Million USD | 0.0% |
2016 FY | -13.17 Million USD | 8.98% |
2015 Q1 | -2.74 Million USD | 23.97% |
2015 Q3 | -4.49 Million USD | -63.91% |
2015 Q4 | -4.49 Million USD | 0.0% |
2015 FY | -14.47 Million USD | 5.13% |
2015 Q2 | -2.74 Million USD | 0.0% |
2014 Q2 | -4.02 Million USD | 0.0% |
2014 FY | -15.25 Million USD | 5.68% |
2014 Q4 | -3.6 Million USD | 0.0% |
2014 Q3 | -3.6 Million USD | 10.32% |
2014 Q1 | -4.02 Million USD | 3.47% |
2013 Q2 | -3.92 Million USD | 0.0% |
2013 FY | -16.17 Million USD | -36.26% |
2013 Q1 | -3.92 Million USD | -32.54% |
2013 Q3 | -4.16 Million USD | -6.23% |
2013 Q4 | -4.16 Million USD | 0.0% |
2012 Q2 | -3.05 Million USD | 0.0% |
2012 Q1 | -3.05 Million USD | -40.12% |
2012 Q3 | -3.03 Million USD | 0.83% |
2012 Q4 | -2.95 Million USD | 2.4% |
2012 FY | -11.87 Million USD | -31.84% |
2011 Q1 | -2.18 Million USD | 20.5% |
2011 Q4 | -2.18 Million USD | 0.0% |
2011 FY | -9 Million USD | 17.97% |
2011 Q2 | -2.18 Million USD | 0.0% |
2011 Q3 | -2.18 Million USD | 0.0% |
2010 Q4 | -2.74 Million USD | 0.0% |
2010 Q2 | -2.74 Million USD | 0.0% |
2010 Q3 | -2.74 Million USD | 0.0% |
2010 Q1 | -2.74 Million USD | 44.69% |
2010 FY | -10.97 Million USD | 46.43% |
2009 Q1 | -4.96 Million USD | -57.54% |
2009 Q3 | -4.96 Million USD | 0.0% |
2009 FY | -20.48 Million USD | -44.41% |
2009 Q4 | -4.96 Million USD | 0.0% |
2009 Q2 | -4.96 Million USD | 0.0% |
2008 Q2 | -3.14 Million USD | 0.0% |
2008 Q4 | -3.14 Million USD | 0.0% |
2008 Q1 | -3.14 Million USD | 3.3% |
2008 Q3 | -3.14 Million USD | 0.0% |
2008 FY | -14.18 Million USD | 2.44% |
2007 Q3 | -3.25 Million USD | 0.0% |
2007 FY | -14.54 Million USD | -49.56% |
2007 Q4 | -3.25 Million USD | 0.0% |
2007 Q1 | -3.25 Million USD | -47.1% |
2007 Q2 | -3.25 Million USD | 0.0% |
2006 Q3 | -2.21 Million USD | 0.0% |
2006 Q2 | -2.21 Million USD | 0.0% |
2006 Q1 | -2.21 Million USD | -79.52% |
2006 FY | -9.72 Million USD | -91.74% |
2006 Q4 | -2.21 Million USD | 0.0% |
2005 FY | -5.07 Million USD | 27.97% |
2005 Q2 | -1.23 Million USD | 0.0% |
2005 Q3 | -1.23 Million USD | 0.0% |
2005 Q1 | -1.23 Million USD | 28.45% |
2005 Q4 | -1.23 Million USD | 0.0% |
2004 Q4 | -1.72 Million USD | 0.0% |
2004 Q2 | -1.72 Million USD | 0.0% |
2004 Q3 | -1.72 Million USD | 0.0% |
2004 Q1 | -1.72 Million USD | 0.0% |
2004 FY | -7.04 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Bionano Genomics, Inc. | -232.49 Million USD | 81.462% |
Prenetics Global Limited | -62.72 Million USD | 31.286% |
Star Equity Holdings, Inc. | -1.54 Million USD | -2684.238% |
CareDx, Inc | -190.28 Million USD | 77.35% |
Exact Sciences Corporation | -204.14 Million USD | 78.888% |
Exagen Inc. | -23.68 Million USD | -81.941% |
Inotiv, Inc. | -105.14 Million USD | 59.007% |
Guardant Health, Inc. | -479.44 Million USD | 91.011% |
Biodesix, Inc. | -52.14 Million USD | 17.347% |
BioNexus Gene Lab Corp. | -2.62 Million USD | -1539.38% |
Precipio, Inc. | -5.85 Million USD | -636.375% |
iSpecimen Inc. | -11.09 Million USD | -288.306% |
Natera, Inc. | -434.8 Million USD | 90.087% |
Aspira Women's Health Inc. | -16.69 Million USD | -158.238% |
Standard BioTools Inc. | -74.65 Million USD | 42.269% |
23andMe Holding Co. | -666.7 Million USD | 93.535% |
Castle Biosciences, Inc. | -57.46 Million USD | 24.999% |
Personalis, Inc. | -108.29 Million USD | 60.202% |
Aclaris Therapeutics, Inc. | -88.48 Million USD | 51.289% |
Applied DNA Sciences, Inc. | -9.94 Million USD | -333.294% |
OpGen, Inc. | -32.66 Million USD | -31.931% |
T2 Biosystems, Inc. | -50.07 Million USD | 13.933% |
Myriad Genetics, Inc. | -112 Million USD | 61.518% |
ICON Public Limited Company | 612.33 Million USD | 107.039% |
NeoGenomics, Inc. | -87.96 Million USD | 51.005% |
Star Equity Holdings, Inc. | -1.54 Million USD | -2684.238% |
IDEXX Laboratories, Inc. | 845.04 Million USD | 105.1% |
RadNet, Inc. | 3.04 Million USD | 1515.9% |
Psychemedics Corporation | -4.15 Million USD | -937.554% |
Illumina, Inc. | -1.16 Billion USD | 96.288% |
Check-Cap Ltd. | -17.56 Million USD | -145.332% |
Twist Bioscience Corporation | -208.72 Million USD | 79.351% |
DarioHealth Corp. | -59.42 Million USD | 27.474% |
Fulgent Genetics, Inc. | -167.82 Million USD | 74.318% |
Sera Prognostics, Inc. | -36.24 Million USD | -18.923% |
ENDRA Life Sciences Inc. | -10.06 Million USD | -328.419% |
OPKO Health, Inc. | -188.86 Million USD | 77.179% |
Medpace Holdings, Inc. | 282.81 Million USD | 115.24% |
Neogen Corporation | -9.42 Million USD | -357.489% |
Intelligent Bio Solutions Inc. | -10.15 Million USD | -324.348% |
Prenetics Global Limited | -62.72 Million USD | 31.286% |
Mainz Biomed B.V. | -26.29 Million USD | -63.905% |
bioAffinity Technologies, Inc. | -7.93 Million USD | -443.026% |
Trinity Biotech plc | -24.01 Million USD | -79.449% |
Neuronetics, Inc. | -30.18 Million USD | -42.767% |
Sotera Health Company | 51.37 Million USD | 183.891% |
bioAffinity Technologies, Inc. | -7.93 Million USD | -443.026% |